中西医结合法治疗慢性盆腔炎的临床疗效观察(1)

http://www.100md.com 2017年3月5日 《医学信息》 2017年第9期

     摘要：目的 为有效治疗女性患者慢性盆腔炎疾病，探究中西联合用于疾病治疗的可行性、有效性。方法 选取2014年7～2015.7期间我院门诊部门收治的慢性盆腔炎女性患者86例，本次临床分组采用双盲法将患者分为西药组、中西组，每组人数均为43例，对患者进行一年后随访记录疾病复发情况。结果 中西组疾病复发率为2.3%，西药组为9.3%，中西组用药治疗后患者疾病复发率较西药组低，P<0.05；中西组炎症改善有效率为97.7%，西药组为86.0%，P<0.05；西药组较中西组血浆粘度C反应蛋白改善效果差，P<0.05。結论 临床对慢性盆腔炎患者采用中西联合进行治疗，患者恢复好、复发率低。

    关键词：疗效；盆腔炎；中西结合；慢性

    Clinical Observation on Treatment of Chronic Pelvic Inflammatory Disease with Traditional Chinese Medicine and Western Medicine
, http://www.100md.com
    WU Yan1，ZHANG Yong-Xin2

    (1.Department of Obstetrics and Gynecology，Rongxian Chinese Medicine Hospital，Zigong 643100，Sichuan，China；

    2.Department of Obstetrics and Gynecology，Rongxian Maternal and Child Health Hospital，Zigong 643100，Sichuan，China)

    Abstract：Objective To effectively treat the disease of chronic pelvic inflammatory disease in female patients，and to explore the feasibility and effectiveness of the combination of Chinese and Western diseases for disease treatment.Methods A total of 86 patients with chronic pelvic inflammatory disease were enrolled in the outpatient department from July 2014 to February in 2015.The patients were divided into western medicine group and middle and western group.The number of patients in each group was 43 cases.A year after follow-up to record the recurrence of the disease.Results The recurrence rate was 2.3% and disease group，9.3% in the western medicine group，western medication group after treatment of patients with disease recurrence rate lower than western medicine group，western group，P<0.05；the effective rate of improvement of inflammation was 97.7% in the western medicine group and the western medicine group was 86.0%，P<0.05；plasma viscosity C reactive protein improvement effect is poor，P<0.05. Conclusion The clinical treatment of patients with chronic pelvic inflammatory disease with the combination of Chinese and Western treatment， patients recovered well，the recurrence rate is low.
, http://www.100md.com
    Key words：Curative effect；Pelvic inflammatory disease；Traditional Chinese and Western Medicine；Chronic

    盆腔炎是由于机体抵抗力下降，细菌侵入感染，导致盆腔腹膜及生殖器官和其周围结缔组织出现的炎症反应，盆腔炎分为急性和慢性，慢性炎症患者多表现精神不佳、周身不适、失眠且伴有下腹坠胀，严重会导致不孕、输卵管妊娠，严重影响患者生活质量与健康[1]。此病多见于生育年龄段女性，且病情迁延易复发发展，临床治疗多以改善患者症状、松解粘连为主。目前临床多使用西药进行抗菌、消炎治疗，从而提高治疗效果。本次我院临床观察中西医联合用于疾病治疗的可行性、有效性，现报道如下。

    1资料与方法

    1.1一般资料 选取2015年4月～2016年5月我院门诊部门收治的慢性盆腔炎女性患者86例，本次临床分组采用双盲法将患者分为西药组、中西组，每组人数均为43例。其中西药组患病时间6个月～3年，平均时间(1.9±0.7)年， 年龄31～48岁，平均年龄(40.6±1.7)岁；中西医组患病时间7个月～4年，平均时间(2.1±0.6)年，年龄29～47岁，平均年龄(40.9±1.6)岁，2组患者临床均出现不同程度腹痛、白带增多、腹胀等症状，一般资料差别无意义，P>0.05，可进行比较，本次研究经医院伦理委员会批准。, http://www.100md.com(吴燕 张永新)

第 1 2 页 下一页

    百拇医药网 http://www.100md.com/html/paper/1006-1959B/2017/09/73.htm